Haselmeier Revenue and Competitors

Your Partner from Technology to therapy - As expert in subcutaneous drug delivery systems for self-administration, Haselmeier provides innovative and award-winning individual system solutions to support patients for a successful therapy. Haselmeier primarily works with pharmaceutical and biotechnology companies to improve the lives of patients by manufacturing pens and auto-injectors that are convenient, reliable and that can be dosed with precision. The family business covers all steps – from design to planning to industrialization – in the creation of high-quality self-injection systems. In 2020, this well-established company will be able to look back on a 100-year-old success story. Spread across seven global locations on three different continents, the Haselmeier Group employs a workforce of more than 240 people. Since 2020, we have belonged to Sulzer AG, a globally active Swiss industrial corporation.